Annual Current Liabilities
$13.00 M
+$2.15 M+19.86%
31 March 2022
Summary:
Sio Gene Therapies annual total current liabilities is currently $13.00 million, with the most recent change of +$2.15 million (+19.86%) on 31 March 2022. During the last 3 years, it has risen by +$2.15 million (+19.86%).SIOX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$2.15 M
-$2.68 M-55.48%
31 December 2022
Summary:
Sio Gene Therapies quarterly total current liabilities is currently $2.15 million, with the most recent change of -$2.68 million (-55.48%) on 31 December 2022.SIOX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +19.9% | -85.8% |
| 5 y5 years | -70.1% | -93.0% |
SIOX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -72.1% | -96.0% |
Sio Gene Therapies Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $2.15 M(-55.5%) |
| Sept 2022 | - | $4.83 M(-47.2%) |
| June 2022 | - | $9.15 M(-29.6%) |
| Mar 2022 | $13.00 M(+19.9%) | $13.00 M(-14.1%) |
| Dec 2021 | - | $15.14 M(+46.9%) |
| Sept 2021 | - | $10.31 M(+35.7%) |
| June 2021 | - | $7.59 M(-30.0%) |
| Mar 2021 | $10.85 M(-66.1%) | $10.85 M(+21.2%) |
| Dec 2020 | - | $8.95 M(-10.9%) |
| Sept 2020 | - | $10.04 M(-18.9%) |
| June 2020 | - | $12.38 M(-61.4%) |
| Mar 2020 | $32.04 M(-26.3%) | $32.04 M(+4.4%) |
| Dec 2019 | - | $30.69 M(-35.1%) |
| Sept 2019 | - | $47.28 M(-12.5%) |
| June 2019 | - | $54.03 M(+24.2%) |
| Mar 2019 | $43.50 M | $43.50 M(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | - | $45.20 M(-7.7%) |
| Sept 2018 | - | $49.00 M(+12.6%) |
| June 2018 | - | $43.51 M(-6.6%) |
| Mar 2018 | $46.58 M(+0.7%) | $46.58 M(+10.5%) |
| Dec 2017 | - | $42.14 M(+3.0%) |
| Sept 2017 | - | $40.90 M(-19.9%) |
| June 2017 | - | $51.05 M(+10.3%) |
| Mar 2017 | $46.27 M(+193.7%) | $46.27 M(+16.8%) |
| Dec 2016 | - | $39.59 M(+38.2%) |
| Sept 2016 | - | $28.64 M(+69.2%) |
| June 2016 | - | $16.93 M(+7.5%) |
| Mar 2016 | $15.76 M(+307.3%) | $15.76 M(-0.9%) |
| Dec 2015 | - | $15.89 M(+53.1%) |
| Sept 2015 | - | $10.38 M(+127.1%) |
| June 2015 | - | $4.57 M |
| Mar 2015 | $3.87 M | - |
FAQ
- What is Sio Gene Therapies annual total current liabilities?
- What is the all time high annual current liabilities for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sio Gene Therapies?
What is Sio Gene Therapies annual total current liabilities?
The current annual current liabilities of SIOX is $13.00 M
What is the all time high annual current liabilities for Sio Gene Therapies?
Sio Gene Therapies all-time high annual total current liabilities is $46.58 M
What is Sio Gene Therapies quarterly total current liabilities?
The current quarterly current liabilities of SIOX is $2.15 M
What is the all time high quarterly current liabilities for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly total current liabilities is $54.03 M